ECSP099836A - Macrociclos y sus usos - Google Patents

Macrociclos y sus usos

Info

Publication number
ECSP099836A
ECSP099836A EC2009009836A ECSP099836A ECSP099836A EC SP099836 A ECSP099836 A EC SP099836A EC 2009009836 A EC2009009836 A EC 2009009836A EC SP099836 A ECSP099836 A EC SP099836A EC SP099836 A ECSP099836 A EC SP099836A
Authority
EC
Ecuador
Prior art keywords
macrociclos
diseases
prevention
improvement
useful
Prior art date
Application number
EC2009009836A
Other languages
English (en)
Inventor
Roger Aki Fujimoto
Matthew J Lamarche
Philipp Krastel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP099836A publication Critical patent/ECSP099836A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente solicitud describe compuestos orgánicos que son útiles para el tratamiento, prevención y/o mejoría de enfermedades.
EC2009009836A 2007-06-04 2009-12-30 Macrociclos y sus usos ECSP099836A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94177707P 2007-06-04 2007-06-04

Publications (1)

Publication Number Publication Date
ECSP099836A true ECSP099836A (es) 2010-01-29

Family

ID=40094226

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009836A ECSP099836A (es) 2007-06-04 2009-12-30 Macrociclos y sus usos

Country Status (24)

Country Link
US (2) US8476224B2 (es)
EP (1) EP2170907A2 (es)
JP (1) JP2010529076A (es)
KR (1) KR101202483B1 (es)
CN (1) CN101772506B (es)
AR (1) AR066865A1 (es)
AU (1) AU2008258639B2 (es)
BR (1) BRPI0812340A2 (es)
CA (1) CA2688621A1 (es)
CL (1) CL2008001613A1 (es)
CO (1) CO6270222A2 (es)
CR (1) CR11158A (es)
EA (1) EA200901613A1 (es)
EC (1) ECSP099836A (es)
GT (1) GT200900310A (es)
IL (1) IL202285A0 (es)
MA (1) MA31562B1 (es)
MX (1) MX2009013214A (es)
NZ (1) NZ581917A (es)
PE (1) PE20090318A1 (es)
TN (1) TN2009000495A1 (es)
TW (1) TW200902540A (es)
WO (1) WO2008148754A2 (es)
ZA (1) ZA200908262B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2229386B1 (en) 2007-12-12 2015-06-03 Novartis AG An aminothiazole derivative as antibacterial agent
WO2018073269A1 (en) * 2016-10-21 2018-04-26 Xellia Pharmaceuticals Aps Liquid formulations of daptomycin
CN109485617B (zh) * 2018-12-11 2023-01-31 贵州永诺菲特生物制药有限公司 一种n-甲基-2-异丙基-4-噻唑甲胺的制备方法
US20260109695A1 (en) * 2022-08-26 2026-04-23 Wake Forest University Health Sciences Peroxiredoxin 3 inhibitors and methods of use for treating cancer
WO2025038747A1 (en) * 2023-08-14 2025-02-20 Rs Oncology, Llc Modified thiostrepton-inspired compounds for treatment of cancer and preparation thereof
WO2025265000A1 (en) * 2024-06-21 2025-12-26 Rs Oncology, Llc Modified thiostrepton-inspired compounds for treatment of cancer and preparation thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2071143T3 (es) 1990-03-08 1995-06-16 Lepetit Spa Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.
DE9004073U1 (de) 1990-04-07 1990-06-13 Auto-Kabel Hausen GmbH & Co. Betriebs-KG, 79688 Hausen Anschlußklemme für Akkumulator o.dgl.
IL100572A (en) 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
DK0529410T3 (da) * 1991-08-30 1998-05-11 Biosearch Italia Spa Antibiotikum GE 2270 faktor C2a
ES2186866T3 (es) * 1996-02-14 2003-05-16 Biosearch Italia Spa Derivados de factores del antibiotico ge2270.
JPH1059997A (ja) * 1996-08-22 1998-03-03 Microbial Chem Res Found アミチアマイシンアミド誘導体
KR20050026401A (ko) * 2002-06-17 2005-03-15 비큐론 파마세티컬스 인코포레이티드 여드름 치료를 위한 ｇｅ 2270 인자 ａ3의 아미드유도체의 용도
US20050106159A1 (en) * 2003-08-12 2005-05-19 Thompson Stuart A. Campylobacter jejuni outer membrane protein immunogenic composition
AR060977A1 (es) 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
BRPI0720542A2 (pt) * 2006-12-20 2014-01-21 Novartis Ag Compostos antibacterianos e processos para a sua produção

Also Published As

Publication number Publication date
AU2008258639A1 (en) 2008-12-11
MX2009013214A (es) 2010-01-15
BRPI0812340A2 (pt) 2015-01-27
CN101772506A (zh) 2010-07-07
WO2008148754A2 (en) 2008-12-11
WO2008148754A3 (en) 2009-03-05
NZ581917A (en) 2011-04-29
TN2009000495A1 (en) 2011-03-31
EP2170907A2 (en) 2010-04-07
US20130252883A1 (en) 2013-09-26
ZA200908262B (en) 2010-08-25
US8691756B2 (en) 2014-04-08
PE20090318A1 (es) 2009-04-17
US20090186830A1 (en) 2009-07-23
CL2008001613A1 (es) 2009-05-15
CN101772506B (zh) 2014-02-12
KR20100021496A (ko) 2010-02-24
EA200901613A1 (ru) 2010-06-30
KR101202483B1 (ko) 2012-11-16
MA31562B1 (fr) 2010-08-02
AR066865A1 (es) 2009-09-16
CR11158A (es) 2010-01-20
CO6270222A2 (es) 2011-04-20
IL202285A0 (en) 2010-06-16
JP2010529076A (ja) 2010-08-26
GT200900310A (es) 2010-05-21
TW200902540A (en) 2009-01-16
CA2688621A1 (en) 2008-12-11
US8476224B2 (en) 2013-07-02
AU2008258639B2 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
CR10433A (es) Compuestos organicos y sus usos
CR10336A (es) Compuestos organicos y sus usos
UY32123A (es) Derivados de n - (sustituido) - 4 - (but-2-iniloxi) - benzamida, sus racematos, diastereòmeros, enantiòmeros y las sales de los mismos y aplicaciones
UY32551A (es) Compuestos peptidomiméticos de sulfamida y usos antivirales de los mismos
CR10310A (es) Compuestos nuevos
UY32554A (es) Compuestos peptidomiméticos de sulfonamida y usos antivirales de los mismos
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
GT201200220A (es) Ciertas triazolopiridinas y triazolopirazinas, composiciones de estas y sus métodos de empleo
CR20150217A (es) Inhibidores de histona demetilasas
SV2009003307A (es) Quinazolinas para la inhibicion de pdk1
ECSP11011541A (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida
EA200900798A1 (ru) Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы
ECSP088922A (es) Derivados de amino-tiazol y sus usos como agentes antibacterianos
UY34165A (es) ?compuestos aldh-2 mitocondriales humanos para el tratamiento de la adicción?.
CR20120303A (es) Tratamientos para trastornos gastrointestinales
ECSP099836A (es) Macrociclos y sus usos
AR060402A1 (es) Compuestos organicos y sus usos
CL2012001758A1 (es) Uso de compuestos derivados de 8-hidroxiquinolin-7-carboxamida y sus sales, para el tratamiento y/o prevencion de infecciones fungicas.
CU20100119A7 (es) Compuestos orgánicos de aminotiazoles
UY31424A1 (es) Compuestos de 2,3-dihidro-benzofurano
UY31425A1 (es) Compuestos de fenilpirrolidina
GT200800263A (es) Derivados de amino-tiazol y sus usos como agentes antibacterianos